Follow
Low JG
Low JG
Dr
Verified email at singhealth.com.sg
Title
Cited by
Cited by
Year
Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore
BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan, J Loh, OT Ng, ...
Jama 323 (15), 1488-1494, 2020
24872020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ...
Nature 584 (7821), 457-462, 2020
20222020
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ...
Cell reports 34 (6), 2021
6232021
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ...
The Lancet Microbe 2 (6), e240-e249, 2021
3652021
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)
CW Tan, LP Ho, S Kalimuddin, BPZ Cherng, YE Teh, SY Thien, HM Wong, ...
Nutrition 79, 111017, 2020
3542020
Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness
L Tanner, M Schreiber, JGH Low, A Ong, T Tolfvenstam, YL Lai, LC Ng, ...
PLoS neglected tropical diseases 2 (3), e196, 2008
3072008
A dynamic immune response shapes COVID-19 progression
EZ Ong, YFZ Chan, WY Leong, NMY Lee, S Kalimuddin, SMH Mohideen, ...
Cell host & microbe 27 (6), 879-882. e2, 2020
3042020
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
N Le Bert, HE Clapham, AT Tan, WN Chia, CYL Tham, JM Lim, ...
Journal of Experimental Medicine 218 (5), e20202617, 2021
3032021
Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa
ALH Kwa, CS Loh, JGH Low, A Kurup, VH Tam
Clinical infectious diseases 41 (5), 754-757, 2005
2442005
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
JG Low, C Sung, L Wijaya, Y Wei, APS Rathore, S Watanabe, BH Tan, ...
The Lancet infectious diseases 14 (8), 706-715, 2014
2322014
Current status of dengue therapeutics research and development
JGH Low, EE Ooi, SG Vasudevan
The Journal of infectious diseases 215 (suppl_2), S96-S102, 2017
2172017
Early Dengue infection and outcome study (EDEN)-study design and preliminary findings
JGH Low, EE Ooi, T Tolfvenstam, YS Leo, ML Hibberd, LC Ng, YL Lai, ...
ANNALS-ACADEMY OF MEDICINE SINGAPORE 35 (11), 783, 2006
2022006
Discovery and genomic characterization of a 382-nucleotide deletion in ORF7b and ORF8 during the early evolution of SARS-CoV-2
YCF Su, DE Anderson, BE Young, M Linster, F Zhu, J Jayakumar, ...
MBio 11 (4), 10.1128/mbio. 01610-20, 2020
1982020
Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity
BE Young, SWX Ong, LFP Ng, DE Anderson, WN Chia, PY Chia, LW Ang, ...
Clinical Infectious Diseases 73 (9), e2932-e2942, 2021
1972021
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
S Kalimuddin, CYL Tham, M Qui, R de Alwis, JXY Sim, JME Lim, HC Tan, ...
Med 2 (6), 682-688. e4, 2021
1932021
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model
APS Rathore, PN Paradkar, S Watanabe, KH Tan, C Sung, JE Connolly, ...
Antiviral research 92 (3), 453-460, 2011
1852011
The early clinical features of dengue in adults: challenges for early clinical diagnosis
JGH Low, A Ong, LK Tan, S Chaterji, A Chow, WY Lim, KW Lee, R Chua, ...
PLoS neglected tropical diseases 5 (5), e1191, 2011
1792011
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
R De Alwis, ES Gan, S Chen, YS Leong, HC Tan, SL Zhang, C Yau, ...
Molecular Therapy 29 (6), 1970-1983, 2021
1392021
Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability
CW Tan, JGH Low, WH Wong, YY Chua, SL Goh, HJ Ng
American journal of hematology 95 (7), E156, 2020
1332020
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
CCL Cheung, D Goh, X Lim, TZ Tien, JCT Lim, JN Lee, B Tan, ZEA Tay, ...
Gut 71 (1), 226-229, 2022
1292022
The system can't perform the operation now. Try again later.
Articles 1–20